Ultra-Sensitive MRD Utilization to Overcome Challenges in Early-Stage Cancer Recurrence Detection
Time: 9:15 am
day: Day Two
Details:
- NeXT Personal is an advanced tumor-informed liquid biopsy assay with ultra-sensitive detection down to 1 PPM
- Ultrasensitive detection with this bespoke whole genome sequencing based assay improves detection of ctDNA at baseline, and during follow-up, with increased lead time over clinical relapse
- Clinical studies in lung and breast cancer establish a strong correlation of NeXT Personal MRD with patient outcome
